Abstract
Transduction efficiency can be easily monitored during pre-clinical trials by inclusion of marker genes. However, the use of such marker genes should be avoided in the final clinical gene therapy application since their products are often immunogenic, making it difficult to monitor transduction, especially if the vector is applied in vivo. In these cases PCR-based methods like the real-time PCR might provide a powerful tool to estimate biodistribution. To investigate the accuracy of this method, we have developed and tested a real-time PCR assay for the quantification of the enhanced green fluorescent protein (EGFP) gene and compared the results with transduction efficiencies estimated by FACS analysis. Although our real-time PCR assay itself was characterized by a high precision over a wide dynamic range of quantification, significant differences in the transduction efficiency compared with FACS data were initially observed. Accurate determination could only be achieved using an optimized multiplex real-time PCR assay, which allows the simultaneous calculation of cell number and EGFP copy number in the same tube. In view of future needs for methods allowing precise and accurate analysis of biodistribution in gene therapy trials, our data highlight the necessity critically to check both parameters in the implemented assay.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mavilio F et al. Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer Blood 1994 83: 1988–1997
Pawliuk R, Eaves CJ, Humphries K . Sustained high-level reconstitution of the hematopoietic system by preselected hematopoietic cells expressing a transduced cell-surface antigen Hum Gene Ther 1997 8: 1595–1604
Levy JP, Muldoon RR, Zolotukhin S, Link CJ . Retroviral transfer and expression of a humanized, red-shifted green fluorescent protein gene into human tumor Nat Biotechnol 1996 14: 610–614
Klein D et al. Rapid identification of viable retrovirus-transduced cells using the green fluorescent protein as a marker Gene Therapy 1997 4: 1256–1260
Levenson VV, Transue ED, Roninson IB . Internal ribosomal entry site-containing retroviral vectors with green fluorescent protein and drug resistance markers Hum Gene Ther 1998 9: 1233–1236
Brenner M . Gene marking Hum Gene Ther 1996 7: 1927–1936
Riddell SR et al. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients Nature Med 1996 2: 216–223
Stipecke R et al. Immune response to green fluorescent protein: implications for gene therapy Gene Therapy 1999 6: 1305–1312
Long Z et al. Biosafety monitoring of patients receiving intracerebral injections of murine retroviral vector producer cells Hum Gene Ther 1998 9: 1165–1172
Long Z et al. Molecular evaluation of biopsy and autopsy specimens from patients receiving in vivo retroviral gene therapy Hum Gene Ther 1999 10: 733–740
Tafuro S, Zentilin L, Falaschi A, Giacca M . Rapid retrovirus titration using competitive polymerase chain reaction Gene Therapy 1996 3: 679–684
Lahijani R et al. Quantitation of host cell DNA contaminate in pharmaceutical-grade plasmid DNA using competitive polymerase chain reaction and enzyme-linked immunosorbent assay Hum Gene Ther 1998 9: 1173–1180
Catzavelos C, Ruedy C, Stewart AK, Dube I . A novel method for the direct quantification of gene transfer into cells using PCR in situ Gene Therapy 1998 5: 755–760
Holland PM, Abramson RD, Watson R, Gelfand DH . Detection of specific polymerase chain reaction product by utilizing the 5′–3′ exonuclease activity of Thermus aquaticus DNA polymerase Proc Natl Acad Sci USA 1991 88: 7276–7280
Gerard CJ et al. A rapid and quantitative assay to estimate gene transfer into retrovirally transduced hematopoietic stem/progenitor cells using a 96-well format PCR and fluorescent detection system universal for MMLV-based proviruses Hum Gene Ther 1996 7: 343–354
Heid CA, Stevens J, Livak KJ, Williams PM . Real time quantitative PCR Genome Res 1996 6: 986–994
Gibson UE, Heid CA, Williams PM . A novel method for real time quantitative RT-PCR Genome Res 1996 6: 995–1001
Sanburn N, Cornetta K . Rapid titer determination using quantitative real-time PCR Gene Therapy 1999 6: 1340–1345
Klein D et al. Proviral load determination of different feline immunodeficiency virus isolates using real-time polymerase chain reaction: influence of mismatches on quantification Electrophoresis 1999 20: 291–299
Paradis K et al. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue Science 1999 285: 1236–1241
Miller AD, Rosman GJ . Improved retroviral vectors for gene transfer and expression Biotechniques 1989 7: 980–990
Varmus HE, Heasley S, Linn J, Wheeler K . Use of alkaline sucrose gradients in a zonal rotor to detect integrated and unintegrated avian sarcoma virus-specific DNA in cells J Virol 1976 18: 574–585
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Klein, D., Bugl, B., Günzburg, W. et al. Accurate estimation of transduction efficiency necessitates a multiplex real-time PCR. Gene Ther 7, 458–463 (2000). https://doi.org/10.1038/sj.gt.3301112
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301112
Keywords
This article is cited by
-
Multiplex real-time PCR for detection and quantification of Colletotrichum abscissum and C. gloeosporioides on Citrus leaves
European Journal of Plant Pathology (2019)
-
Inhibition of cervical cancer cell growth in vitro and in vivo with dual shRNAs
Cancer Gene Therapy (2011)
-
Influence of vector design and host cell on the mechanism of recombination and emergence of mutant subpopulations of replicating retroviral vectors
BMC Molecular Biology (2009)
-
In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery
Gene Therapy (2007)
-
Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain
Gene Therapy (2007)